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Background Despite tremendous advances in the management of cardiovas-
cular diseases and cardiac arrest, there is paucity of information regarding sudden
cardiac death in sub-Saharan Africa. We present a two-year review of sudden car-
diac death cases among patients managed at a Nigerian tertiary hospital. 
Material and Methods Patients admitted from January 2012 to December
2013 were prospectively followed-up and cases of sudden cardiac death iden-
tified. Diagnosis was based on records of events preceding death, direct inter-
view of attending physician/nurses, and family members/eye witnesses
for out-of-hospital sudden cardiac death. Causes of death were obtained from
the death certificates for cases of in-hospital events. 
Results Three hundred and eighty eight (M:F=1:1.3) patients with a
mean age of 42.22±19.30 years were admitted into the cardiac unit during the
period, out of whom 56 (14.4%) died. Twenty three (41.1%) were classified
as sudden cardiac death. The predominant etiology was ischemic cardiomyop-
athy (39.1%), followed by peripartum cardiomyopathy (21.7%) and dilated
cardiomyopathy (17.4%). Rheumatic heart disease was diagnosed in 17.4%,
while 4.3% had pulmonary hypertension. Nineteen (82.6%) of the subjects had
congestive cardiac failure. Hypokalemia and hypocalcaemia were recorded in
2 (8.7%) patients who developed prolongation of the QT interval following
commencement of diuretics. Chest-compression- only cardiopulmonary resus-
citation was attempted in 12 (52.1%) with a success rate of 8.3%. 
Conclusion Sudden cardiac death is common among our patients admitted
with cardiovascular diseases. The most common etiology is ischemic cardio-
myopathy, followed by peripartum cardiomyopathy. Most of the victims
were young, and there were no optimum resuscitative measures.
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Background Systemic sclerosis (SSc) is a multi-systemic disease,
responsible for the occurrence of fibrosis interesting skin and some organs
such as the heart. The rhythm and conduction disturbances are probably
one of the main prognostic factors for heart involvement in systemic scle-
rosis. Conduction disorders are common and generally not serious, and
arrhythmias, especially ventricular ones are more threatening. Performing
Holter ECG. Shows significant abnormal Heart rhythm disturbances per-
centage.
Purpose Make a descriptive analysis of various rhythm disorder and con-
duction defects in a population of patients with SSc.
Materials and methods From December 2010 to June 2014, 234 patients
including 205 women and 29 men with systemic sclerosis were included. Each
patient underwent a baseline ECG, cardiac echo Doppler looking for heart
damages. A cardiac MRI was performed to search a myocardial fibrosis when
segmental wall motion abnormalities were found by echo. 50 Holter ECG has
been performed.
Results All patients were in sinus rhythm. Supra ventricular, ventricular
premature beats or a combination of both were found in 12.8%. Conduction
disorders (first degree AV block, Mobitz 1 AVB, ILBBB, LBBB, RBBB,
LAHB) were found in 11.5%. There have been 3 ventricular tachycardia and
one sudden death among patients treated for ventricular hyperexcitability with
myocardial fibrosis. Of the 50 Holter ECG performed, we recorded an episode
of paroxysmal ACFA, supra ventricular hyperexcitability in 39 patients (78%),
ventricular hyperexcitability in 44 patients (88%), very important in more than
half the cases and often associated with myocardial fibrosis. There was no
high degree conduction disturbances.
Conclusion Rhythm and conduction disorders are frequently encoun-
tered in systemic sclerosis and constitute one of cardiac manifestations
affecting the vital prognosis.
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Introduction Few data are reported on pre-excitation syndrome (PS) in the
elderly. The aim was to investigate the influence of advancing age on clinical
presentation, treatment and long-term outcome of PS. 
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Methods 961 patients referred for PS were referred for PS and electro-
physiological study (EPS). Clinical history, echocardiography and treat-
ment were collected. Patients were followed from 3 months up to 10 years
(5.3±5 years).
Results There were 72 patients ≥60y (mean 68.5±6), 889 patients <60y
(mean 30.5±14). Electrophysiological data and recourse to accessory
pathway (AP) ablation (43% vs. 48.5%, p=0.375) did not significantly differ
between the two groups. Older patients more often had symptomatic forms
(81% vs. 63%, p=0.003) and more often had history of spontaneous atrial
fibrillation (AF)(8% vs. 3%, p=0.01) or poorly-tolerated arrhythmias
(18%vs. 7%, p=0.0009). In multivariable analysis, patients ≥60 had a sig-
nificantly higher risk of history of AF (OR=4.2, 2.1-8.3, p=0.001) and
poorly-tolerated arrhythmias (OR=3.8, 1.8-8.1, p=0.001). In patients who
underwent AP ablation, age ≥60 was associated with an increased risk of
major complication (9.6% vs. 1.9%, p=0.006). During follow-up, occurrence
of AF (13.9% vs. 3.6%, p<0.001) and poorly-tolerated tachycardia (4.2% vs.
0.6%, p=0.001) were more frequent in patients ≥60 although frequency of
ablation failure or recurrence was similar (20% vs. 15.5%, p=0.52). In mul-
tivariable analysis, patients ≥60 had a significantly higher risk of AF
(OR=2.9, 1.2-6.8, p≤0.01).
Conclusions Referring of older patients was infrequent in our clinical prac-
tice (7.5% of patients with a PS). Patients ≥60 have a higher risk of AF and
poorly-tolerated tachycardia both at admission and during follow-up but also
a higher risk of procedure complications. Nevertheless, given a risk of
important complications below 10%, the risk/benefit balance appears to favor
AP ablation in the elderly.
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Introduction Treatment of chronic hepatitis C virus (HCV) infection has
dramatically improved since the advent of direct anti-viral agents, including
Sofosbuvir. Sustained virological response may be achieved in more than 90%
of patients without interferon, ensuring broad use of these regimens. To date,
several thousands of patients have been treated with Sofosbuvir-based regi-
mens worldwide. Since their approval in France, combination therapy is given
to patients with complications, including cirrhosis and life-threatening extra-
hepatic manifestations. 
Methods We analyzed retrospectively the incidence of arrhythmias and
conduction disorder in a cohort of patients treated by Sofosbuvir (new anti-
viral HCV) in our hospital from January 2, 2014 to December 31, 2014. 
Results We observed five cases (1.2%) of severe arrhythmia, including
three cardiac conduction defects, within the first days of Sofosbuvir-based
therapy among 415 patients who had been treated in our center. There
were two females and three males. The median age was 58 (50-75) years.
Two patients were coinfected with HIV. Arrhythmia relapsed when Sofos-
buvir was reintroduced in one patient. Among the 3 conduction disorders,
one patient was under beta-blocker and amiodarone another. A pacemaker
was implanted in all 3 patients with conduction disorders. The three
patients who underwent a pacemaker implantation were not pacemaker-
dependent, on the controls after stopping antiviral treatments (figure 1). 
Conclusion Sofosbuvir seems to have cardiac toxicity. The mechanism
underlying Sofosbuvir cardiotoxicity has to be determined. A particular
attention should be given to patients with a medical history of rhythm
or  conduction abnormalities, including careful monitoring (e.g., Holter
ECG recordings) of cardiac rhythm during the first days of Sofosbuvir
therapy.
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Background Preexcitation syndrome (PS) is a potential cause of sudden
cardiac death; its prognostic assessment is a major issue. The aim was to
assess the contribution of esophageal electrophysiological study (EPS) com-
pared to intracardiac EPS for the prognostic evaluation in patients with PS.
Methods We conducted a prospective single-centre study between
November 1st, 2008 and December 1st, 2014, in patients who underwent both
esophageal and intracardiac EPS for a PS. Accessory pathway effective refrac-
tory period (APERP) and induction of sustained supraventricular tachyarrhyth-
mias (SVT) were noted for both methods.
Results 69 patients were included. 45 (65%) were males and mean age was
36±16 years. There were no significant differences in the induction of SVT
between both methods. APERPs were significantly shorter at esophageal EPS
compared to intracardiac EPS in control state (>40 ms) in 51% of patients, but
APERPs did not decrease significantly after isoproterenol: in these patients
with shorter APERP at esophageal EPS, age and gender was similar to other
patients; APERPs in basal state were shorter than in patients with similar
APERPs at both studies (255±43 vs 281±61)(p0.032), but APERPs after iso-
proterenol were similar (226±33 vs 231±45)(0.55); the shortening of APERP
after infusion of isoproterenol was significantly less than in patients with sim-
ilar APERPs at esophageal and intracardiac EPS (30±31ms vs 49±45
ms)(p<0.05). The sensitivity of esophageal EPS in prognostic assessment was
88% in control state, 100% during isoproterenol infusion. The area under
ROC curve of transesophageal EPS in prognostic assessment based on APERP
measurement was 0.74.
Conclusion Esophageal EPS was a reliable and sensitive method of prog-
nostic assessment in patients with PS. APERP was shorter in 51% of patients
but did not decrease significantly after isoproterenol at esophageal EPS
compared to intracardiac EPS, indicating esophageal EPS-related stress.
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